Per Harding Ibsen

Per Harding Ibsen is a highly experienced professional in vaccine production and process optimization, currently serving as a Senior Specialist at AJ Vaccines since February 2019, focusing on API process optimization, facility ramp-up, and compliance with cGMP and biosecurity regulations. Prior to this role, Per Ibsen held the position of Director at AJ Vaccines A/S from January 2017 to January 2019, where responsibilities included large-scale production of Inactivated Polio Vaccine (IPV), technology transfer, and project management. Earlier experience at Statens Serum Institut spanned 30 years, encompassing roles such as Director and Manager, with a strong emphasis on IPV production, process optimization, human resources management, and compliance with regulatory standards. Educationally, Per Ibsen holds a Master of Biology in Microbiological Sciences and Immunology from the University of Copenhagen.